What Is DACVCP Certification?

What the DACVCP Credential Actually Is

DACVCP stands for Diplomate, American College of Veterinary Clinical Pharmacology. It is a veterinary specialty board certification awarded to veterinarians who complete approved residency-level training in clinical pharmacology and then pass a two-phase examination process. If you have seen the same letters elsewhere, be careful: this article concerns only the veterinary credential administered by the American College of Veterinary Clinical Pharmacology, and nothing here applies to any other certification that happens to share the acronym.

The discipline sits at the intersection of drug science and animal patient care. A veterinary clinical pharmacologist is expected to understand how drugs behave in animals, why responses vary between species and individuals, how to design and interpret studies, and how regulatory frameworks shape what can be prescribed or marketed. For quick definitions of the abbreviation itself, see our short explainers on what DACVCP stands for and the meaning of DACVCP.

The Body Behind It: ACVCP and Its Role

The American College of Veterinary Clinical Pharmacology (ACVCP) governs and administers the credential. It approves residency training programs, evaluates applicants, publishes examination information, appoints an Examination Committee, and oversees recertification through a Maintenance of Certification committee. Passing points on the examinations are recommended by the Examination Committee together with ad hoc reviewers and then approved by the Board.

That last detail matters for anyone searching for a single, fixed passing number. The public pages we reviewed did not verify a fixed numerical pass mark or a current pass rate, so any site quoting a precise figure should be treated with caution. We cover what can and cannot be said in our guides to the DACVCP passing score and the DACVCP pass rate.

Two Phases, One Credential

The complete credential requires both Phase I and Phase II. They test different things and have different entry requirements, so it helps to think of them as distinct hurdles rather than one long exam.

Note that Phase II is scored in points, not by a count of questions. The 200-point total should not be read as 200 questions. For a fuller view of the path, read our overview of DACVCP requirements.

What Candidates Must Master

The preparation curriculum for Phase I is organized into 22 headings drawn from the ACVCP Suggested Blueprint for Phase I, last revised December 2021. These are dated preparation topics, not a verified current or exhaustive exam outline, and the current blueprint documents could not be retrieved during our verification. Treat them as a well-grounded study framework rather than a guarantee of what appears on a given sitting. Our complete guide to all 26 content areas goes deeper on each.

Foundational pharmacology (Domains 1-9)

Organ systems and drug classes (Domains 10-22)

The remaining Phase I headings span organ systems and therapeutic categories: Nervous System, Renal, Cardiovascular, Gastrointestinal, Reproduction, Endocrine, and General and special senses. They continue through Control of inflammation/immunomodulation, Anticancer drugs, Fluid therapy, Anti-infectives, Botanical/Herbals, and Disinfectants/antiseptics. Candidates should expect to connect pharmacology principles to each system, for example linking renal physiology to dose adjustment, or antimicrobial pharmacodynamics to dosing strategy.

The Four Phase II Subject Categories

The current Phase II Examination page lists four subject categories. The percentages for these categories are not published there, so we do not assign weights to them.

• Therapeutics (Domain 23)
• Pharmacokinetics and Therapeutic Drug Monitoring (Domain 24)
• Experimental Design, Statistics and Analytical Methods (Domain 25)
• Regulatory Pharmacology (Domain 26)

Phase II shifts from recall toward application. Written responses and extended matching reward candidates who can reason through a clinical or experimental scenario instead of reciting facts. Note also that a separately indexed Phase II blueprint dated December 2021 contains historical question allocations, but those figures are not current percentages and should not be treated as such under the present ten-group, 200-point format.

The "26" in our domain count is simply the total of the supplied headings (22 Phase I preparation headings plus four Phase II categories). It is not an official combined exam-domain count.

Exam Format and Remote Delivery

The published 2026 administration was delivered remotely using ExamSoft, with Phase I on May 19 and Phase II on June 30. Those dates have passed, and a 2027 schedule was not verified. The dated candidate notice takes precedence for the 2026 delivery arrangement over generic references on the phase pages to a testing location or on-site practice.

Phase I ordinarily runs 08:00-12:00 and 14:00-18:00 local time, which works out to eight active examination hours excluding the break. Phase II ordinarily provides eight active hours as well.

For scheduling details and how to plan around the annual cycle, see our DACVCP exam dates guide.

Eligibility and the Phase II Credentials Package

Phase I is open to applicants who are legally qualified to practice veterinary medicine and who are enrolled in, or have completed, approved ACVCP residency training. The application requires two references. Approved institutional and alternate training routes are described on the ACVCP pages for Becoming a Resident and Residency Training Programs, and the published residency learning outcomes are broad statements that do not establish additional exam-domain counts. Our page on DACVCP training expands on residency pathways.

The publication requirement

Phase II credentials review is where many candidates stall, because it depends on scholarship rather than test performance. The requirements include:

• Two peer-reviewed papers accepted or published by February 1 of the examination year
• At least one paper must be original veterinary clinical pharmacology research
• The other may be original research or an eligible evidence-based systematic review or meta-analysis
• First authorship is required on at least one paper
• Neither paper may have been used for another specialty board
• Publication must not predate the beginning of training by more than two years

Because publication timelines are unpredictable, residents should plan manuscripts early in training instead of waiting until the credentials deadline approaches.

Fees and Registration Mechanics

The published 2026 cycle lists the following charges:

Retakes require payment of the respective examination fee. On refunds, the sources differ: the general fee page permits refunds only for extenuating circumstances accepted by the Board, while the phase pages describe examination fees as nonrefundable. Plan as though fees will not be returned.

A separate page on Becoming a Resident describes USD 75 as a first-year candidate registration fee. The public pages do not establish whether this is identical to, or additional to, the Phase I application charge, so confirm directly with ACVCP rather than assuming either way. For a full cost analysis, see our DACVCP certification cost breakdown.

The Five-Year Window and Annual Deadlines

Applications are ordinarily due October 1 before the examination year, and the intent to sit is due by February 1. The currently dated checklist covers October 1, 2025 and February 1, 2026.

Both phases must be passed within a five-year eligibility period that begins with the first eligible examination year after Phase I approval. ACVCP's own example: approval in December 2025 permits examinations in 2026 through 2030. This is an examination eligibility window, not a credential renewal cycle, and the distinction is easy to miss.

Maintenance of Certification: What Is and Is Not Known

The current ACVCP Committees page confirms that a Maintenance of Certification committee administers recertification. Its detailed linked page requires authorization and could not be accessed. Historical context exists in bylaws approved in June 2018, which in indexed text describe review of maintenance records every two years toward maintenance at ten years. However, the complete legacy file was not retrieved, and its current applicability and the rules affecting current Diplomates remain unverified.

For that reason, we do not state any current renewal hours, fees or interval. If you hold or are pursuing the credential, confirm current maintenance rules with ACVCP directly.

Where Clinical Pharmacologists Work

Veterinary clinical pharmacologists are typically found in settings where drug behavior, safety and evidence matter. Common environments include:

• Academic veterinary colleges, combining teaching, clinical consultation and research
• Pharmaceutical and animal health industry, supporting drug development, dosing strategy and safety assessment
• Regulatory and government roles, where knowledge of Regulatory Pharmacology (Domain 26) is directly applicable
• Diagnostic and therapeutic drug monitoring services, drawing on pharmacokinetics and analytical methods

We do not publish earnings figures here because reliable verified data is limited; see our discussions of DACVCP jobs, the salary guide and whether the certification is worth it for a more careful treatment.

Sequencing Your Preparation Around the Domains

Rather than a generic schedule, order your preparation by dependency. Pharmacokinetics and pharmacodynamics underpin nearly every other heading, so they belong first. A sample progression for the months before Phase I might look like this:

For Phase II, shift emphasis toward Domains 23-26, particularly written-response practice on therapeutics, drug monitoring and study design. Our DACVCP study guide and cheat sheet provide additional structure, and you can pair them with realistic question practice on the main practice test site. If you are weighing the challenge ahead, read how hard the DACVCP exam is.

Frequently Asked Questions